Offer - Urjas Oil for just ₹ 1 X
Tripletop is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Tripletop safe for pregnant women?
Tripletop can have harmful effects in pregnant women. If you experience any discomfort after using Tripletop, then discontinue the use and take your doctor's advice.
Is the use of Tripletop safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Tripletop for breastfeeding women are not known.
What is the effect of Tripletop on the Kidneys?
Using Tripletop does not have any harmful effects on kidneys.
What is the effect of Tripletop on the Liver?
Tripletop is not harmful for the liver.
What is the effect of Tripletop on the Heart?
Using Tripletop does not have any harmful effects on the heart.
Tripletop should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Tripletop unless your doctor advises you to do so -
Is this Tripletop habit forming or addictive?
Forming a habit of Tripletop has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Tripletop will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Tripletop is safe as it does not bear any side effects.
Is it able to treat mental disorders?
Tripletop is unable to treat or cure mental disorders.
Interaction between Food and Tripletop
You can take Tripletop with food.
Interaction between Alcohol and Tripletop
Information about the interaction of Tripletop and alcohol is not currently available because this topic has not been researched yet.
No, Tripletop alone should not be used for ringworm because it is a fungal infection of the skin caused by fungi such as Trichophyton rubrum and Epidermophyton floccosum and Tripletop is not an antifungal agent and it is not effective against fungi. Hence Tripletop should not be used for the treatment of ringworm. For the treatment of ringworm, you can use a combination of Tripletop and antifungal drugs such as miconazole and fluconazole.
Yes, Tripletop is safe to use, if applied in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as skin atrophy (skin thinning), burning or stinging sensation of the skin. If you experience above-mentioned side after using this drug then inform your doctor and follow his/her instructions.
Tripletop is used for the short-term treatment up to 2 weeks and if required then maximum up to 4 weeks. You are advised to use it as directed by your doctor. Do not use this medicine longer than prescribed by your doctor to avoid the unpleasant side effect.
Yes, Tripletop might cause dry skin in few cases only. However, the exact cause behind dry skin is unknown. If you are experiencing excessive dryness of skin after applying this drug then you are advised to use a skin moisturizer. Skin moisturizer should be applied only after 30 minutes of applying this drug so that the Tripletop can be absorbed by the skin.
Yes, Tripletop may cause skin discoloration or color changes. It is a rare side effect of this drug. However, the exact cause behind skin discoloration is not known but it is more likely to occur if the skin is covered with a dressing after applying this drug. So you are advised to not cover your skin with a dressing after applying this drug.
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 889